Pre-exposure prophylaxis (PrEP)

February 15, 2021
Community-based organizations and PrEP implementers now have two more resources to help HIV prevention ambassadors promote the meaningful engagement of communities and potential and current PrEP users in the rollout of oral PrEP for HIV prevention: the HIV Prevention Ambassador Training Package and Toolkit, developed by the OPTIONS Consortium and the CHOICE activity of the EpiC and RISE projects.
January 6, 2021
The PrEP for Pregnant and Breastfeeding Women Toolkit is designed for use by policy makers, program implementers, and healthcare workers to expand provision of PrEP to PBFW. The evidence-informed materials are designed to be adapted to reflect local context and priorities, national policy and guidelines, and implementation context surrounding provision of PrEP to PBFW.
August 13, 2020

The Southern African HIV Clinicians Society (SAHCS) invites you to a CPD accredited CME-meeting.

Date: Thursday, 13 August 2020 from 17h30 to 19h00 SAST

Introduction by Chair | Prof Linda-Gail Bekker

July 21, 2020

AVAC is excited to share a whole new way to visualize and explore the data from our Global PrEP Tracker, a database that documents oral PrEP uptake around the world.

June 23, 2020

Under level 5 and 4 of South Africa’s COVID-19 lockdown regulations adolescent girls and young women (AGYW) aged 14 to 24 years could not meet face-to-face in specially created safe spaces with counsellors, as part of a combination HIV intervention programme.

May 22, 2020

UNAIDS warmly welcomes the announcement that the long-acting injectable cabotegravir is safe and effective in preventing HIV among gay men and other men who have sex with men and transgender women.

May 18, 2020


Heterosexual men are not considered a key population in the HIV response and are mostly absent from pre-exposure prophylaxis (PrEP) studies to date. Yet, South African men face considerable HIV risk.

May 4, 2020




Demo Project


April 14, 2020

The Department of Health aims to make a pill to prevent HIV infection available at all community health centres and primary healthcare clinics in South Africa by end September this year.

December 30, 2019
We examine acceptability of a long‐acting injectable PrEP among HIV‐uninfected women in Zimbabwe, South Africa and two United States phase 2 trial sites.